Evaluating quality of life and social support for head cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the quality of life and independence of patients diagnosed with benign and malignant head tumors before and after surgical intervention. It focuses on understanding how factors such as tumor size, type, malignancy, and location influence patient outcomes. Additionally, the study evaluates perceived social support from significant others, family, and friends, providing a multidimensional view of patient well-being during their treatment journey.

Why it matters

Who can join: the full rules

Inclusion criteria for the study:

-clinical diagnosis of head cancer

Study exclusion criteria:

- cranio-brain injuries and inflammatory brain diseases.

Where it's running

• St. Raphael's Hospital
  Krakow, Lesserpoland, Poland Recruiting

Study contacts

• Study coordinator: Edyta Laska, Ph.
• Email: elaska@afm.edu.pl
• Phone: +48692430150

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Prehabilitation program for patients with head and neck cancer

  This study is testing a prehabilitation program that includes exercise and nutrition support for people with head and neck cancer to see if it helps them feel better before surgery.

  Recruiting at 2 sites University of California, Davis · Sacramento, California and 1 other locations · NCT06722508

• Tinnitus and Hearing Loss in Head and Neck Cancer Treated with Radiotherapy or Chemoradiotherapy

  This study tests whether tinnitus that starts during treatment is linked to later hearing loss in adults with locally advanced head and neck cancer treated with radiotherapy alone or with chemotherapy.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT05946577

• Using Pembrolizumab with Chemotherapy for Head and Neck Cancer

  This study is testing if combining a blood test that checks tumor DNA with chemotherapy and immunotherapy can help people with head and neck cancer get better results than using immunotherapy alone.

  Recruiting Phase 2 University of Chicago · Chicago, Illinois · NCT05420948

• Combining chemotherapy and immunotherapy for head and neck cancer treatment

  This study is testing if combining chemotherapy with immunotherapy drugs can help people with head and neck cancer before surgery and possibly reduce the need for radiation therapy afterward.

  Recruiting at 7 sites Phase 1 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT04722523

• Mapping neurosensory disorders and pain in patients treated for oral cavity and oropharynx cancer

  This study is trying to understand and track nerve-related issues and pain in patients who have been treated for cancers in the mouth and throat.

  Recruiting University Hospital, Clermont-Ferrand · Clermont-Ferrand · NCT04673981

• Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot)

  This pilot test sees if tailoring pain treatment to a patient’s pain type can reduce head and neck cancer pain in adults who haven’t started cancer treatment yet.

  Recruiting Phase 2 Shaukat Khanum Memorial Cancer Hospital & Research Centre · Lahore, Punjab Province · NCT07919444

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.